Alzamend Neuro Inc
USD1.21
+0.05 (+4.31%)
CEO
Stephan Jackman
IPO Date
2021-06-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.14
Prev. Close
$1.16
Day Low
$1.12
Day High
$1.25
52W Low
$0.84
52W High
$3.60
Market Cap
$0.00B
Volume
0.18M
| -0.5 |
| 30 Apr 2023 | FY | 0.0% | 0.0% | -488.5% | -251.5% | 0.00 | 2.03 | -3.5 |
| 30 Apr 2022 | FY | 0.0% | 0.0% | -92.6% | -85.2% | 0.00 | 12.37 | -7.2 |
| 30 Apr 2021 | FY | 0.0% | 0.0% | -250.7% | -173.3% | 0.17 | 3.24 | -191.4 |
| 30 Apr 2020 | FY | 0.0% | 0.0% | -536.7% | -243.1% | 0.00 | 1.83 | -214.9 |
| 30 Apr 2019 | FY | 0.0% | 0.0% | -1534.3% | -324.0% | 0.00 | 1.27 | -161.2 |
| 30 Apr 2018 | FY | 0.0% | 0.0% | -40.2% | -38.6% | 0.00 | 24.98 | -645.3 |
| 30 Apr 2017 | FY | 0.0% | 0.0% | 268.4% | -1186.8% | -1.01 | 0.08 | -243.8 |
| 30 Apr 2016 | FY | 0.0% | 0.0% | 65524.5% | -226.9% | -29.42 | 0.18 | 0.0 |
| -2.1 |
| 31 Jul 2025 | Q1 | 0.0% | 0.0% | -50.6% | -42.7% | 0.00 | 6.03 | -0.4 |
| 30 Apr 2025 | Q4 | 0.0% | 0.0% | -28.7% | -24.8% | 0.00 | 6.58 | -0.6 |
| 31 Jan 2025 | Q3 | 0.0% | 0.0% | -30.1% | -24.9% | 0.00 | 5.44 | -1.5 |
| 31 Oct 2024 | Q2 | 0.0% | 0.0% | -36.3% | -27.2% | 0.00 | 3.80 | -1.0 |
| 31 Jul 2024 | Q1 | 0.0% | 0.0% | 80.4% | -58.4% | 0.00 | 0.49 | -0.7 |
| 30 Apr 2024 | Q4 | 0.0% | 0.0% | 32.8% | -134.8% | -0.12 | 0.14 | -1.4 |
| 31 Jan 2024 | Q3 | 0.0% | 0.0% | 63.5% | -312.3% | -0.11 | 0.16 | -0.6 |
| 31 Oct 2023 | Q2 | 0.0% | 0.0% | 108.3% | -295.4% | 0.00 | 0.21 | -1.0 |